Dr. Carol Feghali-Bostwick - Selected for 2026 Women's History Month Innovation Showcase
Dr. Carol Feghali-Bostwick, Scientific Co-Founder to Thendor Therapeutics, was selected to participate in the Congressional Invention Project's prestigious Women's History Month Innovation Showcase on March 26th in Washington, D.C. As one of the pioneering women innovators chosen for this honor, Dr. Feghali-Bostwick showcased Thendor's innovative antifibrotic platform technology to members of Congress and Capitol Hill staff. The selection recognizes Dr. Feghali-Bostwick's outstanding contributions to advancing treatments for fibrotic diseases and provided a valuable opportunity to engage with policymakers on the importance of biomedical research and innovation. CONGRATULATIONS DR. CAROL FEGHALI-BOSTWICK!